These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25120790)

  • 21. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
    Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
    World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.
    Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY
    Lung; 2009; 187(6):401-11. PubMed ID: 19795170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
    Dyrskjøt L; Zieger K; Kissow Lildal T; Reinert T; Gruselle O; Coche T; Borre M; Ørntoft TF
    Br J Cancer; 2012 Jun; 107(1):116-22. PubMed ID: 22596240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
    Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
    J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
    Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
    Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
    Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
    Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
    Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
    Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
    Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
    Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
    PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cancer/testis antigens in cutaneous T cell lymphomas.
    Häffner AC; Tassis A; Zepter K; Storz M; Tureci O; Burg G; Nestle FO
    Int J Cancer; 2002 Feb; 97(5):668-70. PubMed ID: 11807795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.
    Khalvandi A; Abolhasani M; Madjd Z; Shekarabi M; Kourosh-Arami M; Mohsenzadegan M
    APMIS; 2021 Jun; 129(6):291-303. PubMed ID: 33743542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
    Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
    Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.